OCTOBER 29-30, 2018


 on Darling Island

If you think this is just another cannabis conference… think again.

We showcase leading thinkers and influencers from the across the globe and present the most relevant conversations industry wide. We feature dynamic presentations that focus on science, research, finance, medicine, tech, agriculture, innovation and government policy. We craft an unparalleled event atmosphere with your comfort and overall experience in mind.

Discover evidence based information presented by the leading minds in cannabis.

Connect with cannabis professionals and a high level, global cannabis network.

Accelerate your entry into one of the most exciting and fastest growing markets in the world.

Interested in Speaking at CannaTech?

Do you have something important, fascinating, or game-changing to tell the world about cannabis? Click here to tell us why you should be featured on the world's premier cannabis stage.



CannaTech is thrilled to be working with the amazing team at BuddingTech, Australia’s first medical cannabis accelerator as we prepare for CannaTech Sydney. We are joining forces to create an incredible live event.experience designed to inform, inspire and connect you to the global cannabis industry.


CannaTech Sydney will introduce you to some of the brightest minds in cannabis today. We are importing some of Israel’s strongest contributors, welcoming international speakers from all different verticals of the cannabis industry and featuring some of Australia’s best and brightest.



  • “The Humans of Medical Cannabis” – Patient Stories and Case Studies 
  • Groundbreaking and Innovative Clinical Trials
  • Emerging Science and Study about Addiction and Treatment
  • What’s New in Israeli Medical Science


  • Navigating the Global Cannabis Investment Landscape
  • The Opportunity in Ancillary Products
  • Investment Ideas for the Thinking Cannabis Investor
  • How to Stay Competitive in an Expanding Global Market
  • Global Trends in Business and Culture


  • Growing Plants for Medicine
  • New Solutions for Age-Old Farming Challenges – New Trends
  • Cannabis Entrepreneurship
  • Next Steps in Cannabis Extraction Technology
  • What’s New in Delivery Methods
  • Data-Driven Insights


  • What’s Working in the International Community
  • Next Steps for Australian Policy
  • Creating International Law and Standards
  • Lessons From Israel’s Five “Green” Books


And so much more…make sure all relevant batteries are charged.

Stay Connected… Join Our CannaTech Insider Newsletter 


AUs Cann Medical cannabis leaders in Australia and Asia
Visit AusCann

AusCann is bringing together leading expertise and operations across all aspects of the medical cannabis value chain, beginning with cultivation and production, through to manufacture and distribution of products.

We are an Australian based company and our aim is to produce and provide high quality, economical and clinically validated cannabis medicines to Australian patients.

Visit Stero

Creso Pharma
Visit Creso Pharma 

Creso Pharma brings the best of cannabis to better the lives of people and animals. It brings pharmaceutical expertise and methodological rigor to the cannabis world and strives for the highest quality in its products. It develops cannabis and hemp derived therapeutic, nutraceutical, and life style products with wide patient and consumer reach for human and animal health. Creso uses GMP development and manufacturing standards for its products as a reference of quality excellence with initial product registrations in Switzerland. It has worldwide rights for a number of unique and proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids.


Mammoth Microbes is the first product line engineered and produced by Growcentia. Growcentia was founded by a team of three Colorado State University PhD soil microbiologists that share a passion for enhancing soil health and promoting sustainable agriculture. Using innovative proprietary technology, this team developed an approach to identify and apply nature’s very best microbes to improve nutrient availability to plants. Growcentia aims to help growers maximize the health of their soils or growth media to enhance plant health and yields, while minimizing environmental impacts of agriculture.

Visit CannRx
Our Company's mission is to develop high-quality pharmaceutical and analytical products utilizing the cannabis plant by leveraging the patented technology and established botanical expertise of Izun Pharma Limited.


Visit BioCeuticals

BioCeuticals is Australia’s leading provider of practitioner-only nutritional and therapeutic supplements. As a progressive force in integrative health, BioCeuticals believes practitioner advice is key to optimal health treatment outcomes.
BioCeuticals strives to be the first choice and recommendation for integrative health practitioners, no matter where they choose to practice, and is committed to research and practitioner support programs. Our formulations are based on the principles of naturopathic and evidence-based medicine, and the essence of the BioCeuticals brand is underpinned by five guiding pillars: health, knowledge, integrity, leadership and humanity.
Leaders in innovative supplements, integrative health, research and practitioner support.

MGC Pharma
Visit The MGC Pharma online

MGC Pharmaceuticals is a publicly traded (ASX: MXC) BioPharma company with a focus on Phytocannabinoid Medications. MGC Pharma has created a seamless, highly-supervised supply chain, from growing through to API level extraction, with global operations providing proprietary Phytocannabinoid formulations to companies, consumers, researchers and patients worldwide. MGC Pharma’s medications (currently in clinical trials) for treatment areas such as Neurology, Oncology and Palliative Care, are the company's initial steps into registered pharmaceuticals with global distribution networks. With research activities in various fields in Europe, Australia and Israel, MGC Pharma intends to impact global health and wellness via the judicious use of Phytocannabinoid across multiple markets.

MediPharm Labs
Visit MediPharm Labs 

MediPharm Labs Inc (MPL) is a medicinal cannabis company specializing in the pharmaceutical production of oil products.

A Licensed Manufacturer from Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), MediPharm Labs recently became Canada’s first ever cannabis oil-only licensed producer.

MediPharm Labs is also in late stages of its application in Australia under the Office of Drug Control (ODC). MediPharm Labs extraction facility is based in the southern part of Victoria and is partnering now with many local cultivators.

Using highly innovative extraction technologies, MediPharm Labs produces superior products designed for specific patient solutions.

Medical Cannabis Council
Visit The Medical Cannabis Council 
The Medical Cannabis Council is Australia's peak national industry association representing cultivators, manufacturers, distributors, ancillary organisations, education and advocacy groups, researchers and more. Currently representing around 70% of the industry, and expanding into several new territories around the world, the Council focusses on lobbying, education, and general industry networking.

We are the respected voice of this burgeoning industry, with Members comprised of leading businesses and organisations ranging from large multinationals to Australian start-ups.

Visit Tali Pais
Tali Pais
Visit Tali Pais

Event planning for the business and private sector. Our goal is to create a high-quality and unique events, while paying attention to every small detail and to the guest's experience


Visit Gavita

Gavita is the largest specialized horticultural lighting company in the world. We are active on all five continents with projects ranging from single fixtures to large greenhouses with well over 100,000 fixtures, serving the retail, research and professional horticultural market.
Our roots are in horticulture, but since 2010 we have a strong focus on retail too. We develop products for residential and small business use, but we also support projects in new markets.
As a market leader, we constantly innovate, but we will never bring products to the market which are not tested and proven in real life scenarios. This is why Gavita products are the gold standard in lighting with unsurpassed reliability, the lowest cost of ownership and the best return on investment.

Bod Australia

Visit Bod Australia

Bod Australia Limited operates two integrated business units. The Company is a developer and distributor of cosmetics and health supplements, focused on all natural, evidence based products. Bod has developed a significant distribution footprint in the Australian market with access to over 900 pharmacies and is also targeting Asian markets through key daigou relationships. Bod Australia is also building a sustainable, multi-faceted cannabis business through a supply and collaboration agreement with Swiss botanical extract manufacturer, Linnea Natural Pharma Solutions. The Company aims to develop a range of therapeutic and over the counter products based on GMP-certified cannabis and hemp extracts.

Laura Kam
Visit Laura Kam
Whether traditional print and electronic media or social media worldwide, Kam Global Strategies can get your message to the specialized reporters in your field or to the masses through story positioning, background briefings or op-ed placements.

Visit Alvit 

Alvit LCS Pharma focuses on the development of novel drugs that are based on combining proprietary formulations and dosage forms with unique and standardized cannabis extracts. Alvit is a world leader in the development of cannabis based pharmaceuticals for known clinical indications where cannabinoids have been found to be effective.

Alvit is positioned to continue leading the world in the standardization, optimization, and delivery of effective, convenient and safe alternatives to smoking medicinal cannabis.


Visit EverBlu Capital 

EverBlu Capital is an Australian based boutique corporate advisory firm. Founded in 2016, EverBlu brings together over 100 years in combined corporate advisory experience, knowledge and relationships. Our culture is to operate in a dynamic and entrepreneurial environment providing a range of products and services to emerging growth companies and our investors across three areas: Corporate advisory and capital markets, Wealth management; and Research. Since inception, the firm has participated in raising over $250m across more than 50 transactions ranging from resources, agriculture, medical cannabis, artificial intelligence and more.

Visit BuddingTech

BuddingTech is a medical cannabis accelerator - BuddingTech identifies and commercialises industry beneficial research, startups and devices and provides the guidance, support and resources required to successfully develop and integrate these projects into the Asia Pacific medical cannabis market. BuddingTech helps bring to market innovative solutions focused on addressing key challenges across the medical cannabis industry.


CMTREX is an IT-driven trading platform which lies at the core of the emergence of a transparent and efficient trading ecosystem for the global legal cannabis and hemp industry. Leveraging off unique IP developed for physical commodities markets, CMTREX provides an omni-channel platform through which sellers offer and sell their inventory while providing buyers with increased selectivity and price transparency in their purchasing activities. CMTREX is Co-founded by Saul Singer, an experienced executive in the global physical commodities markets and iCAN: Israel-Cannabis, the leading integrated ecosystem of expertise, intelligence and product development in the global cannabis industry.


Visit Cann Group

Cann Group is building a world-class business focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia and internationally. The company has established research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients.
Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. It was issued with Australia’s first medicinal cannabis research licence in February 2017, in addition to Australia’s first medicinal cannabis cultivation licence in March 2017.


About Us

Canngea Pty Ltd (Canngea) was established in Australia in March 2017 and is headquartered in Sydney, New South Wales (NSW).

We are investing in leading-edge technologies to produce premium medical grade cannabinoid products for domestic and export markets. This will allow us to produce the highest quality product at the lowest production cost.

Around the world, cannabis oil is being mixed with food grade MCT oil to legally produce tincture and capsule cannabinoid products. Canngea will utilise readily available and proven technology to do both.

Production will be located in a 10,000m2 state-of-the-art cannabis cultivation facility in regional NSW. The project is multi staged with a fitted out header house, grow space, and supporting facilities to allow packaging and shipping final product.

The first-phase target market is the domestic Australian medical market. The second-phase target market is international export.

Ryan Ballantyne

Ryan has more than 14 years of professional experience in retail operations and FMCG logistics, including eight years of executive management in store operations, warehousing and corporate safety consulting.

Ryan completed a Bachelors of Social Science in Organisational Psychology and Philosophy at the University of Cape Town before immigrating to Australia in 2010. He is currently studying an MBA at University of Sydney School of Business.

Martin Bryden

Martin has worked across UK, European and APAC regions in his 17 year sales and marketing career. He has been pivotal in creating commercial revenue growth for clients including Woolworths, Latitude Financial, Bankwest, Qantas, Mercedes, GUCCI and Toyota.

Martin is currently regional director of Appier Pty Ltd for Australia and New Zealand. His core focus as an exceptionally experienced sales and marketing professional has been driving commercial opportunities.

Colin Sergay

Colin is an experienced information technology professional with more than ten years of experience. He has worked in a variety of sectors including insurance, recruitment and finance for clients including Innovation Group, Careers24 and Investec.

Colin is experienced in the startup space and has been a part of multiple establishment teams. Colin has completed a Bachelor of Science in Information Systems: Software Development (Hons) at CTI Randburg in Johannesburg, South Africa (2010).

Martin Ross
Non-Executive Director - Risk Management and Advisory

Martin is a risk management and compliance expert with more than eight years of experience in his field. His current role is as a HSE management professional with a Tier 1 contractor.

Martin has worked on major infrastructure projects with clients such as BHP Billiton, Santos, Origin Energy, and Samsung C&T/ Roy Hill. Martin’s most recent role was managing risk and legislative compliance on a $100 million project as part of Brisbane Airport’s new runway. He holds a Bachelor of Science and Post-Graduate Diploma from University of Glasgow, Scotland.